In This Issue:
• Change Your Allocation - Despite the latest advance to a new recovery high, we advise moving some money out of dollar-denominated assets.
• In the Limelight
• STARS Status - Changes in S&P analysts' STARS rankings for February 28 through March 4.
• Stocks Ranked One and Two STARS by S&P
• Favored Stocks Near Their 52-Week Lows - We looked for highly ranked stocks priced near the bottom of their trading range. Four of them are appraised here.
• Advice on Widely Held Stocks - Here are our current opinions on five big names that may be in readers' portfolios.
• Three Upgraded Energy Stocks - Our analysts expect these issues to outperform the market over the next 12 months.
• Wal-Mart Looks Like a Bargain
• S&P Sector Scorecard Some of the Companies Featured:
Baker Hughes Inc.
Boston Scientific Corp.
Chevrontexaco Corp.
Cisco Systems Inc.
CVS Corp.
Forest Oil Corp.
General Electric Co.
Intel Corp.
JPMorgan Chase
Neurocrine Biosciences Inc.
Patterson-UTI Energy Inc.
Pfizer Inc.
Polycom Inc.
Smithfield Foods
United Natural Foods
Valspar Corp. | 
